When was ShiraTronics founded?

ShiraTronics was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is ShiraTronics located?

ShiraTronics is headquartered in Minneapolis, United States.

How many employees does ShiraTronics have?

As of Mar 01, 2026, the latest employee count at ShiraTronics is 50 - 199.

Is ShiraTronics a funded company?

ShiraTronics is a funded company, having raised a total of $108M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Nov 05, 2019.

When was the latest funding round of ShiraTronics?

ShiraTronics' latest funding was a $***** Series B round on Sep 17, 2024, with participation from 7 investors. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.63B in funding in 2026 to date.

Where does ShiraTronics rank among its competitors?

ShiraTronics ranks 4th amongst 40 active competitors, of which 9 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was AURIMOD, which secured an undisclosed amount in Sep, 2025.

Who are the top competitors of ShiraTronics?

ShiraTronics' top competitors include Salvia BioElectronics, eNeura and Zosano Pharma. Among them, AURIMOD secured the most recent funding round in September, 2025.

ShiraTronics - 2026 Company Profile, Team, Funding & Competitors

Company Details

ShiraTronics (a spinout from NuXcel) is a developer of neuromodulation devices for treating migraines. The company claims that the implant uses neuromodulation technologies to treat migraine and other chronic diseases. Some of the partners are AMZAK, APERTURE, and LivaNova.

Key Metrics

Founded Year

2019

Location

Minneapolis, United States

Stage

Series B

Total Funding

$108M in 3 rounds

Latest Funding Round

Series B, Sep 17, 2024, $*****

Investors

USVP & 10 more

Ranked

4^th among 40 active competitors

Employee Count

50 - 199 as on Mar 01, 2026

Similar Companies

Salvia BioElectronics & 34 more

View ShiraTronics' full profile

ShiraTronics has raised a total funding of $108M over 3 rounds. Its first funding round was on Nov 05, 2019. Its latest funding round was a Series B round on Sep 17, 2024 for $*****. 7 investors participated in its latest round. ShiraTronics has 11 institutional investors.

Here is the list of recent funding rounds of ShiraTronics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 17, 2024	6046931	Series B	6066624	3682143	4680667	2747068
Aug 11, 2023	3096275	Series A	3403096	2559741	2288370	Strategic Healthcare Investment Partners & 4 more
Nov 05, 2019	6540373	Series A	2859250	9853509	Strategic Healthcare Investment Partners & 2 more	Aperture Venture Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of ShiraTronics's funding rounds and investors

The founders of ShiraTronics is Lynn Elliott.

Here are the details of ShiraTronics' key team members:

Lynn Elliott: Founder & CEO of ShiraTronics.

View details of ShiraTronics's Founder profiles and Board Members

ShiraTronics' employee count trend

ShiraTronics has 50 - 199 employees as of Mar 26. Here is ShiraTronics's employee count trend over the years:

Uncover ShiraTronics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ShiraTronics include Salvia BioElectronics, eNeura and Zosano Pharma. Here is the list of Top 10 competitors of ShiraTronics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Salvia BioElectronics 2017, Eindhoven (Netherlands), Series B	Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders	$88.4M	Panakes Partners, Innovation Industries & 11 others	45/100
2nd	eNeura 2000, Baltimore (United States), Series D	Developer of a transcranial magnetic stimulation device for pain relief	$70.5M	Camden Partners, Domain Associates & 3 others	43/100
3rd	Zosano Pharma 2006, Fremont (United States), Deadpooled	Developer of transdermal drug delivery systems for a broad range of therapeutic indications	$147M	Nomura, ProQuest Investments & 9 others	43/100
4th	ShiraTronics 2019, Minneapolis (United States), Series B	Developer of a neuromodulating device for treating migraine	$108M	Norwest, Amzak Health & 9 others	41/100
5th	Gate Science 2020, Boston (United States), Seed	Developer of a multi-modal device for post-surgery pain	$150K	-	35/100
6th	Cefaly Technology 2005, Herstal (Belgium), Acquired	Neurostimulation devices for the treatment of a migraine and other headaches	-	-	34/100
7th	Nocira 2014, Tempe (United States), Series A	Developing a non-invasive migraine treatment device using gentle air pressure	$3.9M	AZCrown, Padda health	33/100
8th	Realeve 2020, Mountain View (United States), Series A	Developer of a device for the treatment of cranial autonomic disorders	$3M	-	30/100
9th	AURIMOD 2015, Vienna (Austria), Seed	Developer of a medical device for the treatment of pain	-	Convergence Partners, ILUM Tec	29/100
10th	Chordate 2005, Kista (Sweden), Unfunded	Developer of a medical device for the treatment of migraine	-	-	28/100